PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

A Faster, More Flexible, and Frugal FDA?

Setting Sights on the Smart Supply Chain

More Generic Approvals Not Enough
Top Story
Patient Groups Challenged on Pharma Ties
Greater patient involvement in regulatory processes is raising questions about whether the views expressed by such groups fully reflect broader public needs and values. Jill Wechsler reports
… /Read more/
Advertisement
Driving compounds forward
Every molecule presents its own set of challenges. Capsugel's unique combination of drug and process design capabilities – coupled with premier depth in bioavailability enhancement and targeted delivery technologies – enable us to deliver the right solution for meeting those challenges.
To learn more visit
Compliance
What Does the Trump Era Hold for Compliance Regulations?
We know deregulation is coming, but we don't know what it will look like. One looming question for pharmaceutical and medical device companies is about the future of compliance and regulations. Michaeline Daboul reports
… /Read more/
Advertisement
Accelerate the launch of your pharma product, while also easing financial and administrative burdens with 3PL Title Model.
Read more
Europe
Brexit Threatens UK’s Drug Supply
It is hard to resist the sensation that the rhetoric of Shakespeare's Henry V is informing much of the Brexit thinking in Westminster, writes Reflector
… /Read more/
Advertisement
Patient Centricity: Turning Rhetoric into Reality
On Demand
Learn more
Technology
Securing the Pharma Supply Chain: Current Challenges and Key Steps
Jeff R. Livingstone outlines the critical steps necessary to ensure an agile, responsive and streamlined supply chain
… /Read more/
Strategy
Pharma's Understanding of Competitive Intelligence
Despite the investment in place, industry still struggles to take advantage of competitive intelligence as key decision aid, writes Benjamin Gilad
… /Read more/
Calendar
/ April 26–28, 2017: CBI's 14th Annual Pharmaceutical Compliance Congress /
Washington, DC
/ May 11–12: PharmaMarketing Summit 2017 /
Grande Lakes, FL
/ May 21–24: 6th Pharmaceutical Sciences World Congress 2017 /
Stockholm, Sweden
/ June 6–7, 2017: Pharmaceutical Compliance Congress Canada /
Toronto, Canada
/ 20–22 June 2017: EphMRA Annual Conference 2017 /
Amsterdam, The Netherlands
 
Industry update
//Insys Therapeutics (Phoenix, AZ) announced that, effective April 17, 2017, Saeed Motahari, will become the Company's president and chief executive officer and join the company's Board of Directors.//Astellas (Northbrook, IL) announced that John DeMay has been appointed president, Astellas US Technologies, Inc.//Pfenex (San Diego, CA) announced that pharmaceutical industry veterans Sigurdur (Siggi) Olafsson and Jason Grenfell-Gardner have been nominated to serve on the company's Board of Directors. //
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com